Notice: Internet Explorer 11 users may encounter issues loading pages throughout the website. Please turn on IE-11’s compatibility mode while we work to resolve the issue.

>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

HHS Issues Advisory Opinion on the "Company Model"

Friday, June 01, 2012

ASA was pleased to see that the Department of Health and Human Services Office of Inspector General (HHS-OIG) issued an Advisory Opinion (No. 12-06) on a "company model" arrangement and expressed the view that it could violate the federal anti-kickback statute. ASA has repeatedly brought this issue to the attention of the HHS-OIG and in February of this year sent formal communication to Inspector General Levinson outlining ASA's concerns with the "company model."

Under the "company model," referring physicians, who typically also own the facility where surgical procedures are performed, form a separate anesthesia company in order to share in anesthesia revenue.

This Advisory Opinion was issued in response to a request submitted by an anesthesia practice (the "Requestor") regarding two different proposed arrangements, both of which represented a departure from the current practice between the Requestor and the Centers.

Under Proposed Arrangement A, the Requestor would begin paying the Centers a per-patient fee, excluding Federal health care program patients, for "Management Services" such as paying for space in the referring physician's facility and paying for the services of Center personnel to transfer billing documentation to the anesthesiologists' billing office.

Under Proposed Arrangement B, the physician-owners would establish anesthesia companies and engage the Requestor as an independent contractor to provide anesthesia services, paying the Requestor a negotiated rate.

The HHS-OIG concluded that both arrangements posed regulatory concern. 

  • With regard to Proposed Arrangement A, the OIG stated:

Based on the facts presented here, we think there is risk that the Requestor would be paying the Management Services fees with regarding to non-Federal health care program patients to induce the Centers' referral of all of its patients, including Federal health care program beneficiaries.

  • With regard to Proposed Arrangement B, the OIG concluded:

Based on the facts presented here, it appears that Proposed Arrangement B is designed to permit the Centers' physician-owners to do indirectly what they cannot do directly; that is, to receive compensation, in the form of a portion of the Requestor's anesthesia services revenues, in return for their referrals to the Requestor.  This conclusion is consistent with, and supported by, the Requestor's representation that it is under competitive pressures to enter into the Proposed Arrangements to stem the loss of its business.

Significantly, under the "company model" (Proposed Arrangement B), even though the regulatory "safe harbors" might protect the payments to the Requestor (the anesthesiologists), the safe harbors would not protect the distribution of profits to the referring physicians.

Review the HHS-OIG Advisory Opinion.

Review ASA's formal communication to Inspector General Levinson.

« Back to Washington Alerts